GT Biopharma (GTBP) had the highest return between 2010 and 2012 by a US stock, returning 338,299,730%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2010-2012	338,299,730%
QXO (QXO)	2010-2012	4,032,075%
Sequans Communications (SQNS)	2010-2012	2,819,177.11%
Castellum (CTM)	2010-2012	815,117.39%
Ferguson (FERG)	2010-2012	228,186.81%
Aris Mining (ARMN)	2010-2012	29,795.16%
Intellinetics (INLX)	2010-2012	8,066.67%
Versus Systems Inc. (VS)	2010-2012	1,980%
Par Pacific (PARR)	2010-2012	1,900%
BOS Better Online Solutions (BOSC)	2010-2012	1,458.94%
Netcapital (NCPL)	2010-2012	1,300%
Nova Lifestyle I (NVFY)	2010-2012	1,266.67%
Actinium Pharmaceuticals (ATNM)	2010-2012	1,263.64%
N2OFF (NITO)	2010-2012	1,150%
VirnetX Holding Corp Common Stock (VHC)	2010-2012	957.2%
Sunshine Biopharma (SBFM)	2010-2012	941.67%
Predictive Oncology (POAI)	2010-2012	899.88%
3D Systems (DDD)	2010-2012	823.83%
Flotek Industries (FTK)	2010-2012	810.45%
BTCS (BTCS)	2010-2012	760%
Intelligent Protection Management (IPM)	2010-2012	733.33%
Lifevantage (LFVN)	2010-2012	711.12%
Barfresh Food (BRFH)	2010-2012	670%
BioRestorative Therapies (BRTX)	2010-2012	669.23%
Cheniere Energy (LNG)	2010-2012	651.2%